Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.
New COVID-19 vaccine
In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
mRNA vaccine beats infection
Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.
One-and-done COVID-19 drug successful
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
New way to treat COVID-19 smell loss
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
Predicting immunity from vaccination
A gene signature seen in antibody-producing cells in the blood of vaccinated study participants could expedite vaccine development.
Awards for COVID-19 project, media work
A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.
Bertozzi research advances medicine
Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.
What to know about polio
The first polio case in the U.S. since 2013 emerged in July, and cases have increased abroad. Yvonne Maldonado answers questions about the virus and its impacts.
Antivirals may benefit some inpatients
Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Blood Disorders (Hematology)
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Environment & Sustainability
- Epidemiology & Population Health
- Global Health
- Health Policy
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Neurology & Neurosurgery
- Obstetrics & Gynecology
- Palliative Care
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Stanford Medicine
- Stem Cells
- Women's Health